Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Toronto

$353,172.00

Engineering DNAzyme-gold nanoparticle diagnostic device

FY 2017-18

Summary
Mosquitos carry many infectious pathogens that can significantly affect a patient's health as well as other people that the patients come into contact with. Currently, there is a major global scare with the transmission of the Zika virus, which has been implicated in cerebral brain malformations among fetuses and newborns. Given advances in transportation vehicles, there is a significant risk of the virus being imported back to countries where the mosquitos carry it are found. There remains an urgent need to develop simple methods to rapidly diagnose Zika virus infection as it continues to spread to new locations. Rapid diagnosis in areas with reduced access to testing laboratories will allow appropriate management of pregnant women who become infected and implement control measures as the virus spreads to new, often remote areas. Here, in this project, our aim is to develop a unique colour-based test using nanotechnology components to be able to rapidly diagnose patients that are presenting symptoms for the Zika virus, as well as two other important mosquito borne viruses, dengue and chikungunya virus. Testing of the 3 viruses is important to determine proper treatment, as patients infected with either of three viruses may present the same symptoms. We will further develop a smartphone readout system that enables the quantification and monitoring of transmission of Zika virus. A team consisting of an engineer and two medical doctors is assembled to build and test this diagnostic device. Our commercial partners have the infrastructure to build the device and reagents, test the diagnostic systems, and to globally sell and distribute the technology for use in patient care.
Program
Collaborative Health Research Projects (NSERC partnered)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
376809
Name
Chan Warren C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Engineering DNAzyme-gold nanoparticle diagnostic device
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$353,172
Cihrequipment2
$15,000
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Diagnostics; Infectious Disease; Nanotechnology; Point Of Care
Abstract
Mosquitos carry many infectious pathogens that can significantly affect a patient's health as well as other people that the patients come into contact with. Currently, there is a major global scare with the transmission of the Zika virus, which has been implicated in cerebral brain malformations among fetuses and newborns. Given advances in transportation vehicles, there is a significant risk of the virus being imported back to countries where the mosquitos carry it are found. There remains an urgent need to develop simple methods to rapidly diagnose Zika virus infection as it continues to spread to new locations. Rapid diagnosis in areas with reduced access to testing laboratories will allow appropriate management of pregnant women who become infected and implement control measures as the virus spreads to new, often remote areas. Here, in this project, our aim is to develop a unique colour-based test using nanotechnology components to be able to rapidly diagnose patients that are presenting symptoms for the Zika virus, as well as two other important mosquito borne viruses, dengue and chikungunya virus. Testing of the 3 viruses is important to determine proper treatment, as patients infected with either of three viruses may present the same symptoms. We will further develop a smartphone readout system that enables the quantification and monitoring of transmission of Zika virus. A team consisting of an engineer and two medical doctors is assembled to build and test this diagnostic device. Our commercial partners have the infrastructure to build the device and reagents, test the diagnostic systems, and to globally sell and distribute the technology for use in patient care.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chan, Warren C; Arbuckle, John; Gubbay, Jonathan B; Mubareka, Samira
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $353,172~ $15,000~